Gut hormone triggers craving for more proteins
Scienmag
MAY 17, 2021
Revelations from a fly study could improve our understanding of protein malnutrition in humans.
Engineer Hormones Protein 
52 
ARVINAS AND PFIZER ANNOUNCE GLOBAL COLLABORATION TO DEVELOP AND COMMERCIALIZE PROTAC® PROTEIN DEGRADER ARV-471
The Pharma Data
JULY 22, 2021
NYSE: PFE) today announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC® (PROteolysis TArgeting Chimera) estrogen receptor protein degrader. ER is the primary driver of hormone receptor (HR) positive breast cancer, which is the most common breast cancer subtype.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Could an Antibody Drug Help You Shed Pounds?
The Pharma Data
NOVEMBER 2, 2020
That’s one finding from an early study that tested the injection drug, which mimics the effects of a natural hormone called fibroblast growth factor 21 (FGF21). FGF21 is a hormone that helps control metabolism by stimulating certain receptors in fat tissue, the liver, the pancreas and the central nervous system. MONDAY, Nov.
Sanofi Executives Predict 2021 Will be ‘Transformative’ Year for Company
The Pharma Data
JANUARY 7, 2021
He also noted innovations are occurring with protein degraders, antibody conjugates, nanobodies and multi-specific antibodies, specifically bi- and tri-specific. That platform will allow the company to engineer new proteins, Nestle said. billion acquisition of Synthorx. Dupixent is currently approved in the U.S.
From Gene to Protein: The Journey of Protein Expression Technology
Roots Analysis
SEPTEMBER 9, 2024
Over the years, pharmaceutical companies have shifted their priorities from traditional interventions towards more advanced pharmacological strategies, such as protein therapeutics. Further, $400 billion is the anticipated sales of protein-based therapeutics in 2023. The mRNA is then translated into to form functional proteins.
The 4 Biggest Cancer Biotech Acquisitions of 2021 So Far
XTalks
MARCH 22, 2021
Maverick’s COBRA platform is used to engineer protein-based therapies that target T cells in the tumor microenvironment to trigger their activation. Therapies engineered through COBRA are designed to safely target a broad range of solid tumors with highly specific and potent activity while limiting toxicities in normal tissues.
Leading freeze-drying systems suppliers for the pharmaceutical industry
Pharmaceutical Technology
MARCH 10, 2023
Pharmaceutical and biotechnology industries widely use freeze-drying systems to protect vaccines, antibodies, antibiotics such as penicillin, blood plasma, proteins, enzymes, hormones, viruses, and bacteria from heat and minimise their biological activity.
Let's personalize your content